William Haack

Consejero General en

Pointe Conception Medical, Inc.

Distribution Services

Consumer Services

Electronic Technology

Perfil

William Haack is currently the Vice President-Regulatory & Compliance at Pointe Conception Medical, Inc. He previously worked as the Manager-Regulatory & Engineering at Karl Storz Imaging, Inc. and as the VP-Market Access & Business Operations at OncoCyte Corp.
from 2016 to 2018.
Haack is a graduate of The California State University.

Cargos activos de William Haack

Empresas	Cargo	Inicio
Pointe Conception Medical, Inc. Pointe Conception Medical, Inc. Medical DistributorsDistribution Services Manufactures endoscopic camera products	Consejero General	-

Todos los cargos activos de William Haack

Antiguos cargos conocidos de William Haack.

Empresas	Cargo	Fin
INSIGHT MOLECULAR DIAGNOSTICS INC.	Director de Operaciones	06/08/2018
KARL STORZ Imaging, Inc. KARL STORZ Imaging, Inc. Electronic ComponentsElectronic Technology Manufactures lens and optical instruments	Director Técnico/Científico/I+D	-

Ver el detalle de la experiencia de William Haack.

Formación de William Haack.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de William Haack.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	4
Pointe Conception Medical, Inc. Pointe Conception Medical, Inc. Medical DistributorsDistribution Services Manufactures endoscopic camera products	Distribution Services
The California State University The California State University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
KARL STORZ Imaging, Inc. KARL STORZ Imaging, Inc. Electronic ComponentsElectronic Technology Manufactures lens and optical instruments	Electronic Technology
OncoCyte Corp. OncoCyte Corp. BiotechnologyHealth Technology Focuses on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer	Health Technology